d27gayle POSTED INCORRECT INFORMATION ABOUT THE SIDE EFFECTS OF S...
READ THE MESSAGE ABOVE AND YOU WILL NOW SEE: DEPRESSION AND SUICIDAL REFERENCES
IN ADDITION READ THE POST MARKETING EXPERIENCE ON THE BOTTOM OF PAGE 15 OF THE PRESCRIBING INFO FOR SINGULAIR ON THEIR WEBSITE (http://www.merck.com/product/usa/pi_circulars/s/singulair/singulair_pi.pdf)
IT READS:
The following additional adverse reactions have been reported in post-marketing use:
Blood and lymphatic system disorders: increased bleeding tendency
Immune system disorders: hypersensitivity reactions including anaphylaxis, very rarely hepatic eosinophilic infiltration
Psychiatric disorders: agitation including aggressive behavior, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior (including
suicide), tremor
Nervous system disorders: drowsiness, paraesthesia/hypoesthesia, very rarely seizures
Cardiac disorders: palpitations
Respiratory, thoracic and mediastinal disorders: epistaxis
Gastrointestinal disorders: diarrhea, dyspepsia, nausea, very rarely pancreatitis, vomiting
Hepatobiliary disorders: Rare cases of cholestatic hepatitis, hepatocellular liver-injury, and mixedpattern liver injury have been reported in patients treated with SINGULAIR. Most of these occurred in combination with other confounding factors, such as use of other medications, or when SINGULAIR was administered to patients who had underlying potential for liver disease such as alcohol use or other forms of hepatitis.
Skin and subcutaneous tissue disorders: angioedema, bruising, erythema nodosum, pruritus, urticaria
Musculoskeletal and connective tissue disorders: arthralgia, myalgia including muscle cramps
General disorders and administration site conditions: edema
In rare cases, patients with asthma on therapy with SINGULAIR may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. These events usually, but not always, have been associated with the reduction of oral corticosteroid therapy. Physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between SINGULAIR and these underlying conditions has not been established (see PRECAUTIONS, Eosinophilic Conditions).
this is the address for the patient info on Singulair
http://www.merck.com/product/usa/pi_circulars/s/singulair/singulair_ppi.pdf
Make a reply to this posting:
Singulair RSS FeedRelated Tags
pins and needles numbness seizures convulsions inflammation of the pancreas side effects of singulair pins and needles upper respiratory infection inflammation pain muscle cramps stomach pain suicidal behavior stuffy nose sinuses allergic reactions indigestion pancreas tiredness joint pain merck rash depression connective tissue disorders systemic corticosteroid therapy strauss syndrome churg strauss liver injury immune system disorders lymphatic system subcutaneous tissue gastrointestinal disorders nervous system disorders hypoesthesia cardiac disorders liver disease hypersensitivity reactions nodosum singulair clinical features rare cases psychiatric disorders patient info circulars ppi pi
